FDA Approval Update for Azathioprine Supplement by Rising
The FDA has granted an Abbreviated New Drug Application (ANDA) approval for a supplement of Azathioprine by Rising.
Asset / Drug
Drug and asset intelligence for Azathioprine with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.